CVR: 34459975
Previous names: SYNACTION PHARMA ApS
Selskabets formål er at udvikle lægemidler og dermed relateret virksomhed samt enhver aktivitet, der efter direktionens skøn står i forbindelse hermed.
| Year | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2024 | -26.3 mio. | -30.5 mio. | 37.8 mio. | 25.1 mio. | 4 | |
Compared to 130 companies in Fremstilling af farmaceutiske præparater
Comparison is based on industry median values
Ann Kristin Brøgger Led joined as director
Björn Uno Bernhard Westberg left as director
Companies in the same industry and area
CVR 35419543
CVR 40259724
CVR 38034871
CVR 37016845
CVR 16279099